Search

Sean E. Aeder

Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1939
Issued Applications
907
Pending Applications
201
Abandoned Applications
855

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7470670 [patent_doc_number] => 20040096855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Genes' [patent_app_type] => new [patent_app_number] => 10/444190 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23761 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096855.pdf [firstpage_image] =>[orig_patent_app_number] => 10444190 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/444190
Genes May 22, 2003 Abandoned
Array ( [id] => 220857 [patent_doc_number] => 07608403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell' [patent_app_type] => utility [patent_app_number] => 10/514771 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4240 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608403.pdf [firstpage_image] =>[orig_patent_app_number] => 10514771 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514771
Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell May 19, 2003 Issued
Array ( [id] => 6865124 [patent_doc_number] => 20030190650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Screening method' [patent_app_type] => new [patent_app_number] => 10/332130 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17085 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190650.pdf [firstpage_image] =>[orig_patent_app_number] => 10332130 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/332130
Screening method May 18, 2003 Abandoned
Array ( [id] => 5747800 [patent_doc_number] => 20060110731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Cancer-linked gene as target for chemotherapy' [patent_app_type] => utility [patent_app_number] => 10/514535 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13214 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110731.pdf [firstpage_image] =>[orig_patent_app_number] => 10514535 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514535
Cancer-linked gene as target for chemotherapy May 14, 2003 Abandoned
Array ( [id] => 5743169 [patent_doc_number] => 20060088894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Prostate cancer biomarkers' [patent_app_type] => utility [patent_app_number] => 10/513649 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22146 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088894.pdf [firstpage_image] =>[orig_patent_app_number] => 10513649 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/513649
Prostate cancer biomarkers May 8, 2003 Abandoned
Array ( [id] => 7382198 [patent_doc_number] => 20040029157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Cell cycle control protein' [patent_app_type] => new [patent_app_number] => 10/429849 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7708 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029157.pdf [firstpage_image] =>[orig_patent_app_number] => 10429849 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/429849
Cell cycle control protein May 5, 2003 Abandoned
Array ( [id] => 7361671 [patent_doc_number] => 20040014659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/428164 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20784 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014659.pdf [firstpage_image] =>[orig_patent_app_number] => 10428164 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/428164
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof May 1, 2003 Abandoned
Array ( [id] => 7362514 [patent_doc_number] => 20040005302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Encapsulated cells to elicit immune responses' [patent_app_type] => new [patent_app_number] => 10/428519 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15090 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005302.pdf [firstpage_image] =>[orig_patent_app_number] => 10428519 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/428519
Encapsulated cells to elicit immune responses Apr 29, 2003 Abandoned
Array ( [id] => 7429722 [patent_doc_number] => 20040001844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/421198 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9843 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001844.pdf [firstpage_image] =>[orig_patent_app_number] => 10421198 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/421198
Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof Apr 21, 2003 Abandoned
Array ( [id] => 6701587 [patent_doc_number] => 20030224467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'AIB1 as a prognostic marker and predictor of resistance to endocrine therapy' [patent_app_type] => new [patent_app_number] => 10/418027 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 37213 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224467.pdf [firstpage_image] =>[orig_patent_app_number] => 10418027 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/418027
AIB1 as a prognostic marker and predictor of resistance to endocrine therapy Apr 16, 2003 Abandoned
Array ( [id] => 7545580 [patent_doc_number] => 08053552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Neopeptides and methods useful for detection and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/511698 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 16866 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053552.pdf [firstpage_image] =>[orig_patent_app_number] => 10511698 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/511698
Neopeptides and methods useful for detection and treatment of cancer Apr 16, 2003 Issued
Array ( [id] => 63392 [patent_doc_number] => 07759068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Use of substances for treating tumors' [patent_app_type] => utility [patent_app_number] => 10/511205 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5257 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759068.pdf [firstpage_image] =>[orig_patent_app_number] => 10511205 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/511205
Use of substances for treating tumors Apr 14, 2003 Issued
Array ( [id] => 7393217 [patent_doc_number] => 20040038259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Method of producing a temporally spaced subtracted (TSS) cDNA library and uses thereof' [patent_app_type] => new [patent_app_number] => 10/412987 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17668 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038259.pdf [firstpage_image] =>[orig_patent_app_number] => 10412987 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/412987
mda-9 protein Apr 13, 2003 Issued
Array ( [id] => 7039292 [patent_doc_number] => 20050158726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Compositons and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene' [patent_app_type] => utility [patent_app_number] => 10/511813 [patent_app_country] => US [patent_app_date] => 2003-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13556 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158726.pdf [firstpage_image] =>[orig_patent_app_number] => 10511813 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/511813
Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene Apr 11, 2003 Issued
Array ( [id] => 6931130 [patent_doc_number] => 20050282165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Diagnosis of Carcinoma Using RAIG1 Polypeptides' [patent_app_type] => utility [patent_app_number] => 10/510507 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15528 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282165.pdf [firstpage_image] =>[orig_patent_app_number] => 10510507 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/510507
Diagnosis of Carcinoma Using RAIG1 Polypeptides Apr 9, 2003 Abandoned
Array ( [id] => 893991 [patent_doc_number] => 07341721 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'β2-microglobulin (β2m) and anti-β2m binding agents as anti-cancer therapeutics' [patent_app_type] => utility [patent_app_number] => 10/410798 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 13494 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/341/07341721.pdf [firstpage_image] =>[orig_patent_app_number] => 10410798 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/410798
β2-microglobulin (β2m) and anti-β2m binding agents as anti-cancer therapeutics Apr 9, 2003 Issued
Array ( [id] => 33987 [patent_doc_number] => 07786278 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Modified CEA nucleic acid and expression vectors' [patent_app_type] => utility [patent_app_number] => 10/510677 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13646 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786278.pdf [firstpage_image] =>[orig_patent_app_number] => 10510677 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/510677
Modified CEA nucleic acid and expression vectors Apr 8, 2003 Issued
Array ( [id] => 7227945 [patent_doc_number] => 20050255468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Method for discrimination of metaplasias from neoplastic or preneoplastic lesions' [patent_app_type] => utility [patent_app_number] => 10/511108 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5321 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255468.pdf [firstpage_image] =>[orig_patent_app_number] => 10511108 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/511108
Method for discrimination of metaplasias from neoplastic or preneoplastic lesions Apr 7, 2003 Issued
Array ( [id] => 5230316 [patent_doc_number] => 20070292423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Method of Defining the Differentiation Grade of Tumor' [patent_app_type] => utility [patent_app_number] => 10/552178 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12907 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292423.pdf [firstpage_image] =>[orig_patent_app_number] => 10552178 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/552178
Method of Defining the Differentiation Grade of Tumor Apr 7, 2003 Abandoned
Array ( [id] => 6865162 [patent_doc_number] => 20030190688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Methods for detecting BCR-ABL signaling activity in tissues using phospho-specific antibodies' [patent_app_type] => new [patent_app_number] => 10/408486 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11151 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190688.pdf [firstpage_image] =>[orig_patent_app_number] => 10408486 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/408486
Methods for detecting BCR-ABL signaling activity in tissues using phospho-specific antibodies Apr 6, 2003 Abandoned
Menu